VIDEO: Expert discusses precision medicine in mood disorders

Manpreet Kaur Singh, MD, MS, spoke with Healio about her presentation on personalized treatment selection for mood disorders using biotypes at this year’s NEI Congress.

“The talk that I gave [outlines] some conceptual effects of understanding what precision medicine is, what it looks like in fields other than psychiatry and neuroscience — like in cancer— and work still necessary to continue to iterate towards better and to help clinicians also define biotypes and biomarkers, understand the differences between them, and figure out a practical way of imaging how these really creative and innovative tools can be practically implemented in the clinical setting, in the patient encounter,” Singh, an associate professor of psychiatry and behavioral sciences at Stanford University, told Healio.

She explained that precision medicine tools are being created to “address patient unmet needs related to the fact that they don’t often feel like they have the right medication the first time that they’re being treated, or that they’ve had to endure several trial failures or have had difficulties experiencing success in treatment, and that could potentially lead to an erosion of trust in the physician, in the interventionalist [and] the system more broadly.”